A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of IoGen for the Treatment of Moderate or Severe, Periodic Breast Pain Associated With Symptomatic Fibrocystic Breast Disease

Trial Profile

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of IoGen for the Treatment of Moderate or Severe, Periodic Breast Pain Associated With Symptomatic Fibrocystic Breast Disease

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 26 Jul 2007

At a glance

  • Drugs Iodine (Primary)
  • Indications Breast pain
  • Focus Therapeutic Use
  • Sponsors Symbollon Pharmaceuticals
  • Most Recent Events

    • 26 Jul 2007 The expected completion date for this trial is now 1 Mar 2008.
    • 15 Jun 2007 Status change from recruiting to in progress.
    • 02 Feb 2007 New trial cetnres added.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top